2016
DOI: 10.5301/ijao.5000506
|View full text |Cite
|
Sign up to set email alerts
|

Blood Damage in Ventricular Assist Devices

Abstract: leading to adverse events and focus on the development of less traumatic pumps. It is commonly agreed that a major part of the complications are related to device-induced effects on blood. On their way through the pump and its cannulae, blood components are subjected to strong influences that may either damage cells or proteins or enhance thrombogenesis. Although intensive research has been focused on blood damage, the underlying mechanisms are still not well understood in their entire complexity. This special… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
15
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 25 publications
(27 reference statements)
0
15
0
Order By: Relevance
“…A widely adopted approach to estimate blood damage is the use of numerical damage prediction models implemented into flow simulations (computational fluid dynamics (CFD)). 7 Many of those models base on the evaluation of shear stresses. [8][9][10][11][12][13][14] Numerical blood damage estimation is currently confined on the use of unsteady Reynolds-averaged Navier-Stokes (URANS) simulations.…”
Section: Introductionmentioning
confidence: 99%
“…A widely adopted approach to estimate blood damage is the use of numerical damage prediction models implemented into flow simulations (computational fluid dynamics (CFD)). 7 Many of those models base on the evaluation of shear stresses. [8][9][10][11][12][13][14] Numerical blood damage estimation is currently confined on the use of unsteady Reynolds-averaged Navier-Stokes (URANS) simulations.…”
Section: Introductionmentioning
confidence: 99%
“…Over the years, extensive research has been conducted to improve device thromboresistance, focusing, in particular, on the optimization of the pump geometry as a means of reducing hypershear within the pump. [18][19][20][21][22][23] However, despite significant technological advancements, postimplant thrombosis continues to occur even with the latest generation of devices, suggesting involvement of other factors beyond pump hypershear. Moreover, although LVAD systems that abated the occurrence of in-pump thrombosis are now commercially available, these are not free from thromboembolic events (namely stroke).…”
Section: Introductionmentioning
confidence: 99%
“…1 The blood pump is widely used in the treatment of heart failure, such as bridge-to-recovery, bridge-to-transplantation, or destination therapies. 2,3 The main function of the blood pump is to drive the blood in the ventricle to flow into the artery. The non-physiological shear stress generated in the flow field will damage the blood, and destroy red blood cells and platelet activation, resulting in serious hemolysis and thrombosis, as well as endangering the life of patients.…”
Section: Introductionmentioning
confidence: 99%